16th Jan 2024 4:40 pm |
RNS |
GSK announces intention to sell shares in Haleon |
16th Jan 2024 3:30 pm |
RNS |
Director/PDMR Shareholding |
10th Jan 2024 7:00 am |
RNS |
Nucala approved in China for use in severe asthma |
9th Jan 2024 7:00 am |
RNS |
GSK enters agreement to acquire Aiolos Bio |
2nd Jan 2024 3:00 pm |
RNS |
Total Voting Rights |
21st Dec 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
20th Dec 2023 4:44 pm |
RNS |
Publication of EMTN Suppl.Prospcts |
18th Dec 2023 7:00 am |
RNS |
Jemperli plus Zejula Trial Meets Endpoint |
13th Dec 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
12th Dec 2023 7:00 am |
RNS |
Japan accepts Arexvy filing for at risk adults |
11th Dec 2023 7:00 am |
RNS |
Jemperli plus chemotherapy EU authorisation |
4th Dec 2023 3:02 pm |
RNS |
GSK publishes provisional 2024 dividend dates |
1st Dec 2023 3:00 pm |
RNS |
Total Voting Rights |
30th Nov 2023 9:00 am |
RNS |
Block Listing Application |
29th Nov 2023 3:23 pm |
RNS |
Holding(s) in Company |
27th Nov 2023 7:00 am |
RNS |
GSK announces positive DREAMM-7 headline results |
21st Nov 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
15th Nov 2023 3:00 pm |
RNS |
Block listing Interim Review |
13th Nov 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
13th Nov 2023 7:00 am |
RNS |
GSK receives positive CHMP opinion for momelotinib |
1st Nov 2023 3:00 pm |
RNS |
Total Voting Rights |
1st Nov 2023 7:00 am |
RNS |
3rd Quarter Results |
30th Oct 2023 7:00 am |
RNS |
Jemperli trial meets overall survival endpoint |
26th Oct 2023 7:00 am |
RNS |
NMPA approves Vocabria+Rekambys in China |
25th Oct 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
25th Oct 2023 7:00 am |
RNS |
New data for Arexvy, GSK’s RSV vaccine |
20th Oct 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
18th Oct 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
17th Oct 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
16th Oct 2023 7:00 am |
RNS |
Jemperli plus chemotherapy positive CHMP opinion |
13th Oct 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
12th Oct 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
11th Oct 2023 7:00 am |
RNS |
Zantac (ranitidine) litigation |
10th Oct 2023 11:00 am |
RNS |
Holding(s) in Company |
9th Oct 2023 7:00 am |
RNS |
GSK and Zhifei announce vaccine partnership |
6th Oct 2023 7:00 am |
RNS |
GSK completes sale of shares in Haleon plc |
5th Oct 2023 4:46 pm |
RNS |
GSK announces intention to sell shares in Haleon |
2nd Oct 2023 3:00 pm |
RNS |
Total Voting Rights |
27th Sep 2023 3:00 pm |
RNS |
Directorate Change |
25th Sep 2023 7:00 am |
RNS |
GSK RSV vaccine for older adults approved in Japan |